FTC orders Illumina to divest cancer test maker Grail on competition grounds By: MarketWatch April 03, 2023 at 13:39 PM EDT Illumina acquired Grail in 2021 despite concerns from regulators in the U.S. and Europe. The company will appeal the FTC decision. Read More >> Related Stocks: Illumina Inc S&P Biotech SPDR
